$LPRO
Open Lending Corp

2022 Q1 Form 10-Q Financial Statement

#000162828022013049 Filed on May 06, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $50.07M $51.63M $44.01M
YoY Change 13.77% 30.27% 152.48%
Cost Of Revenue $4.788M $4.739M $3.362M
YoY Change 42.42% 59.56% 34.75%
Gross Profit $45.28M $46.89M $40.65M
YoY Change 11.4% 27.89% 172.15%
Gross Profit Margin 90.44% 90.82% 92.36%
Selling, General & Admin $11.22M $9.944M $10.61M
YoY Change 5.71% -15.01% 87.87%
% of Gross Profit 24.77% 21.21% 26.1%
Research & Development $1.823M $1.720M $591.0K
YoY Change 208.46% 152.94% 64.62%
% of Gross Profit 4.03% 3.67% 1.45%
Depreciation & Amortization $304.0K $293.0K $388.0K
YoY Change -21.65% -55.61% 1337.04%
% of Gross Profit 0.67% 0.62% 0.95%
Operating Expenses $13.04M $11.66M $11.20M
YoY Change 16.41% -5.78% 86.48%
Operating Profit $32.24M $35.23M $29.45M
YoY Change 9.5% 45.05% 229.78%
Interest Expense $803.0K -$453.0K $3.289M
YoY Change -75.59% -87.13% 330.5%
% of Operating Profit 2.49% -1.29% 11.17%
Other Income/Expense, Net $0.00 $11.00K -$131.0K
YoY Change -100.0% -100.25% -13200.0%
Pretax Income $31.46M $34.79M $17.33M
YoY Change 81.54% 112.23% 111.8%
Income Tax $8.300M $6.945M $4.500M
% Of Pretax Income 26.38% 19.97% 25.96%
Net Earnings $23.15M $27.84M $12.86M
YoY Change 80.02% 83.13% 57.39%
Net Earnings / Revenue 46.25% 53.92% 29.23%
Basic Earnings Per Share $0.18 $0.10
Diluted Earnings Per Share $0.18 $220.6K $0.10
COMMON SHARES
Basic Shares Outstanding 126.2M shares 126.2M shares 126.8M shares
Diluted Shares Outstanding 126.2M shares 126.8M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $147.4M $116.5M $127.0M
YoY Change 16.07% 14.73% 21066.67%
Cash & Equivalents $147.4M $116.5M $127.0M
Short-Term Investments
Other Short-Term Assets $1.749M $4.873M $980.0K
YoY Change 78.47% 141.48% 880.0%
Inventory
Prepaid Expenses $2.479M $932.0K
Receivables $8.060M $6.525M $6.803M
Other Receivables $2.090M $1.345M $0.00
Total Short-Term Assets $220.6M $202.8M $191.1M
YoY Change 15.44% 24.58% 27199.0%
LONG-TERM ASSETS
Property, Plant & Equipment $2.792M $2.663M $1.608M
YoY Change 73.63% 121.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $157.0K $262.0K $124.0K
YoY Change 26.61% 111.29%
Total Long-Term Assets $122.1M $116.0M $135.7M
YoY Change -10.0% -11.58% -51.93%
TOTAL ASSETS
Total Short-Term Assets $220.6M $202.8M $191.1M
Total Long-Term Assets $122.1M $116.0M $135.7M
Total Assets $342.7M $318.8M $326.8M
YoY Change 4.88% 8.44% 15.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $195.0K $1.285M $2.991M
YoY Change -93.48% -62.67% 232.33%
Accrued Expenses $5.510M $3.984M $3.994M
YoY Change 37.96% 31.36% 1897.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.125M $3.125M $3.125M
YoY Change 0.0% -36.07%
Total Short-Term Liabilities $12.41M $12.07M $19.01M
YoY Change -34.72% -29.06% 1257.86%
LONG-TERM LIABILITIES
Long-Term Debt $142.4M $143.1M $170.2M
YoY Change -16.32% -6.36%
Other Long-Term Liabilities $4.508M $0.00 $92.37M
YoY Change -95.12% -100.0% 862.18%
Total Long-Term Liabilities $142.4M $143.1M $262.6M
YoY Change -45.76% -6.37% 2635.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.41M $12.07M $19.01M
Total Long-Term Liabilities $142.4M $143.1M $262.6M
Total Liabilities $159.4M $159.8M $286.6M
YoY Change -44.4% -40.22% 2505.55%
SHAREHOLDERS EQUITY
Retained Earnings -$259.3M -$282.4M -$415.5M
YoY Change -37.6% -34.07%
Common Stock $1.282M $1.282M $1.282M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $56.68M $56.84M $37.50M
YoY Change 51.14% 51.58%
Treasury Stock Shares 1.980M shares 1.985M shares 1.395M shares
Shareholders Equity $183.4M $159.0M $40.19M
YoY Change
Total Liabilities & Shareholders Equity $342.7M $318.8M $326.8M
YoY Change 4.88% 8.44% 15.48%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income $23.15M $27.84M $12.86M
YoY Change 80.02% 83.13% 57.39%
Depreciation, Depletion And Amortization $304.0K $293.0K $388.0K
YoY Change -21.65% -55.61% 1337.04%
Cash From Operating Activities $31.93M $26.73M $18.84M
YoY Change 69.54% 223.64% 166.22%
INVESTING ACTIVITIES
Capital Expenditures $186.0K -$202.0K $3.000K
YoY Change 6100.0% 102.0% -96.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$186.0K -$202.0K -$3.000K
YoY Change 6100.0% 102.0% -96.39%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change -100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$820.0K -782.0K $6.662M
YoY Change -112.31% -96.41% -71.56%
NET CHANGE
Cash From Operating Activities $31.93M 26.73M $18.84M
Cash From Investing Activities -$186.0K -202.0K -$3.000K
Cash From Financing Activities -$820.0K -782.0K $6.662M
Net Change In Cash $30.93M 25.75M $25.49M
YoY Change 21.31% -289.05% -16.18%
FREE CASH FLOW
Cash From Operating Activities $31.93M $26.73M $18.84M
Capital Expenditures $186.0K -$202.0K $3.000K
Free Cash Flow $31.75M $26.94M $18.83M
YoY Change 68.57% 222.19% 169.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001806201
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39326
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
OPEN LENDING CORPORATION
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-5031428
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1501 S. MoPac Expressway
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 450
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78746
CY2022Q1 dei City Area Code
CityAreaCode
512
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
892-0400
CY2022Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
LPRO
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
126217955 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147404000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116454000 USD
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
3031000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3055000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8060000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6525000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
58265000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
70542000 USD
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2090000 USD
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1345000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1749000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4873000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
220599000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
202794000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2792000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2663000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5048000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5189000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
49187000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
42414000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
64949000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
65503000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
157000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
262000 USD
CY2022Q1 us-gaap Assets
Assets
342732000 USD
CY2021Q4 us-gaap Assets
Assets
318825000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
195000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1285000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5510000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3984000 USD
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
3125000 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3125000 USD
CY2022Q1 lpro Liability For Claims And Claims Adjustment Expense Current
LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent
3029000 USD
CY2021Q4 lpro Liability For Claims And Claims Adjustment Expense Current
LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent
3050000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
550000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
621000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12409000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12065000 USD
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
142437000 USD
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
143135000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4508000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4643000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
159354000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
159843000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128198185 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126217955 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128198185 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126212876 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1282000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1282000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
498057000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
496983000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-259285000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-282439000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1980230 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1985309 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
56676000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
56844000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
183378000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
158982000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
342732000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
318825000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50068000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44008000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4788000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3362000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
388000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
141000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
134000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
45280000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
40646000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7482000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8212000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3733000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2397000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1823000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
591000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
13038000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
11200000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
32242000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29446000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
803000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
3289000 USD
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
25000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
84000 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8778000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-131000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31464000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17332000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8310000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4470000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
23154000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12862000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126215698 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126803096 shares
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8778000 USD
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126216197 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126837832 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
158982000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1281000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-39000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
23154000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
183378000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
26622000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
701000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12862000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
40185000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
23154000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12862000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1281000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
701000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
304000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
554000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1330000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1535000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2451000 USD
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-5504000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
7876000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3066000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1979000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1090000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-611000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1526000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
478000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-745000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3151000 USD
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-119000 USD
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-140000 USD
CY2022Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-21000 USD
CY2021Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
62000 USD
CY2022Q1 lpro Accrued Deferred Financing Costs
AccruedDeferredFinancingCosts
0 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-88000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
50000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31932000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18835000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
186000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-186000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3000 USD
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
125000000 USD
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2021Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
50000000 USD
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
781000 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
166847000 USD
CY2022Q1 lpro Payments Of Deferred Financings Costs
PaymentsOfDeferredFinancingsCosts
0 USD
CY2021Q1 lpro Payments Of Deferred Financings Costs
PaymentsOfDeferredFinancingsCosts
1491000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
39000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104148000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-820000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6662000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30926000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25494000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119509000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150435000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129642000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
721000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
2722000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8501000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-16000 USD
CY2022Q1 lpro Accrued Intangible Assets Costs
AccruedIntangibleAssetsCosts
0 USD
CY2021Q1 lpro Accrued Intangible Assets Costs
AccruedIntangibleAssetsCosts
463000 USD
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q1 lpro Accrued Deferred Financing Costs
AccruedDeferredFinancingCosts
178000 USD
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
The Company’s two largest insurance carrier partners accounted for 38% and 14% of the Company’s total revenue during the three months ended March 31, 2022 and accounted for 44% and 22% of the Company's total revenue during the three months ended March 31, 2021. In the event that one or more of the Company’s significant insurance carriers terminates their relationship with the Company, it could have a material and adverse effect on the Company’s business and, in turn, its revenue. Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, restricted cash, accounts receivable and contract assets to the extent of the amounts recorded on the balance sheets.<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are deposited in commercial analysis and savings accounts at two financial institutions, both with high credit standing. Restricted cash relates to funds held by the Company on behalf of the insurance carriers, delegated for the use of insurance claim payments. Restricted cash is deposited in commercial analysis accounts at one financial institution. The Company has not experienced any losses on its deposits of cash and cash equivalents and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the Company had one customer that individually accounted for 10% of the Company’s accounts receivable. At December 31, 2021, the Company had two customers that each represented 10% of the Company’s accounts receivable. </span></div>The Company does not have material accounts receivable or contract asset balances that are past due and has not written off any balance in its portfolio for the periods presented. The allowance for expected credit losses on accounts receivable and contract assets receivable was less than $0.2 million at March 31, 2022 and December 31, 2021.
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
200000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
200000 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates, and those differences may be material. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognized prospectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant items subject to such estimates and assumptions include, but are not limited to, profit share revenue recognition and the corresponding impact on contract assets, the recognition of the valuations of share-based compensation arrangements, and assessing the realizability of deferred tax assets. These estimates, although based on actual historical trend and modeling, may potentially show significant variances over time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with profit share revenue recognition and the estimation of contract assets under Accounting Standards Update (“ASU”) 2014-9, Revenue from Contracts with Customers (Topic 606) (“ASC 606”), the Company uses forecasts of loan-level earned premium and insurance claim payments. These forecasts are driven by the projection of loan defaults, prepayments and default severity rates. These assumptions are based on the Company’s observations of the historical behavior for loans with similar risk characteristics. The assumptions also take into consideration the forecast adjustments under various macroeconomic conditions, including the current mix of the underlying portfolio of our insurance partners. Management has accordingly adjusted these assumptions during the first three months of 2022 as a result of changes in facts and circumstances and general market conditions.</span></div>
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
112956000 USD
CY2022Q1 us-gaap Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination
47425000 USD
CY2022Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-2641000 USD
CY2022Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
19800000 USD
CY2022Q1 lpro Payments Received From Insurance Carriers
PaymentsReceivedFromInsuranceCarriers
35818000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-48000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
107452000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
58300000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
70500000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
49200000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
42400000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
701000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1281000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1313000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1396000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
145562000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
146260000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3125000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3125000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
142437000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
143135000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8800000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1300000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1281000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
701000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
194348 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
33.56
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5808 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
33.56
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
188540 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
33.56
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
15236000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y7D
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23154000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12862000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126215698 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126803096 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
23154000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12862000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126215698 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126803096 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
499 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
34736 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126216197 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126837832 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
742386 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
299053 shares
CY2021Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
612745 shares
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8300000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4500000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.265
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.258

Files In Submission

Name View Source Status
0001628280-22-013049-index-headers.html Edgar Link pending
0001628280-22-013049-index.html Edgar Link pending
0001628280-22-013049.txt Edgar Link pending
0001628280-22-013049-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lpro-20220331.htm Edgar Link pending
lpro-20220331.xsd Edgar Link pending
lpro-20220331ex311.htm Edgar Link pending
lpro-20220331ex312.htm Edgar Link pending
lpro-20220331ex321.htm Edgar Link pending
lpro-20220331ex322.htm Edgar Link pending
lpro-20220331_cal.xml Edgar Link unprocessable
lpro-20220331_def.xml Edgar Link unprocessable
lpro-20220331_g1.jpg Edgar Link pending
lpro-20220331_htm.xml Edgar Link completed
lpro-20220331_lab.xml Edgar Link unprocessable
lpro-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending